Isolation, characterization and antihyperlipidemic activity of secoisolariciresinol diglucoside in poloxamer-407-induced experimental hyperlipidemia

Pharmaceutical Biology

Volumn 52, Issue 9, 2014, Pages 1094-1103

  Zanwar, Anand A ^a,b   Hegde, Mahabaleshwar V ^b   Rojatkar, Supada R ^a   Sonawane, Kiran B ^c   Rajamohanan, P R ^c   Bodhankar, Subhash L ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^b BHARATI VIDYAPEETH UNIVERSITY   (India)

^c NATIONAL CHEMICAL LABORATORY   (India)

Author keywords

Column chromatography; Flaxseed; Linum usitatissimum

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; POLOXAMER; SECOISOLARICIRESINOL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; WATER; ANTILIPEMIC AGENT; BUTANEDIOL; GLUCOSIDE; SECOISOLARICIRESINOL DIGLUCOSIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERLIPIDEMIC ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHOLESTEROL BLOOD LEVEL; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DISEASE MODEL; DISTORTIONLESS ENHANCEMENT BY POLARIZATION TRANSFER; DRUG ACTIVITY; DRUG ISOLATION; DRUG STRUCTURE; HETERONUCLEAR MULTIPLE BOND CORRELATION; HETERONUCLEAR SINGLE QUANTUM COHERENCE; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HOMONUCLEAR CORRELATION SPECTROSCOPY; HYPERLIPIDEMIA; LINSEED; LIPID BLOOD LEVEL; MASS SPECTROMETRY; MOUSE; NONHUMAN; OPTICAL ROTATION; PROTON NUCLEAR MAGNETIC RESONANCE; ROTATING FRAME OVERHAUSER ENHANCEMENT SPECTROSCOPY; SPECTROSCOPY; STEREOCHEMISTRY; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; ULTRAVIOLET SPECTROSCOPY; ANIMAL; BLOOD; CHEMISTRY; FLAX; HYPERLIPIDEMIAS; ISOLATION AND PURIFICATION; PROCEDURES; RAT; THIN LAYER CHROMATOGRAPHY;

ANIMALS; BUTYLENE GLYCOLS; CHROMATOGRAPHY, THIN LAYER; DISEASE MODELS, ANIMAL; FLAX; GLUCOSIDES; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; LIPIDS; MICE; POLOXAMER; RATS; SPECTRUM ANALYSIS;

EID: 84906046678     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2013.877492     Document Type: Article

References (22)

1. Bakke JE, Klosterman HJ. (1956). A new diglucoside from flaxseed. Proceed North Dakota Acad Sci 10:18-21.
2. Chimichi S, Bambagiotti-Alberti M, Coran SA, et al. (1999). Complete assignment of the 1H and 13C NMR spectra of secoisolariciresinol diglucoside, a mammalian lignan precursor isolated from Linum usitatissimum. Magn Reson Chem 37:860-3.
3. Coran SA, Giannellini V, Alberti MB. (2004). High-performance thinlayer chromatographic-densitometric determination of secoisolariciresinol diglucoside in flaxseed. J Chromatogr A 1045:217-22.
4. Duan XJ, Zhang WW, Li XM, Gui B. (2006). Evaluation of antioxidant property of extract and fractions obtained from a red alga, Polysiphonia urceolata. Food Chem 95:37-43.
5. Eliasson C, Eldin AD, Andersson A, Man PA. (2003). High-performance liquid chromatographic analysis of secoisolariciresinol diglucoside and hydroxycinnamic acid glucosides in flaxseed by alkaline extraction. J Chromatogr A 1012:151-9.
6. Friedwald WT, Levy RI, Fredrickson DS. (1972). Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 18:499-502.
7. Hosseinian FS, Muir AD, Westcott ND, Krol ES. (2006). Antioxidant capacity of flaxseed lignans in two model systems. J Am Oil Chem Soc 83:835-40.
8. Johnsson P, Kamal-Eldin A, Lundgren LN, Aman P. (2000). HPLC method for analysis of secoisolariciresinol diglucoside in flaxseeds. J Agric Food Chem 48:5216-19.
9. Johnston TP, Palmer WK. (1993). Mechanism of poloxamer 407- induced hypertriglyceridemia in the rat. Biochem Pharmacol 46: 1037-42.
10. Kasote DM. (2013). Flaxseed phenolics as natural antioxidants. Int Food Res J 20:27-34.
11. Lemay A, Dodin S, Kadri N, et al. (2002). Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women. Obstet Gynecol 100:495-504.
12. Muir AD, Westcott ND. (2000). Quantitation of the lignan secoisolariciresinol diglucoside in baked goods containing flax seed or flax meal. J Agric Food Chem 48:4048-52.
13. Pellizzon MA, Billheimer JT, Bloedon LT, et al. (2007). Flaxseed reduces plasma cholesterol levels in hypercholesterolemic mouse models. J Am Coll Nutr 26:66-75.
14. Prasad K. (1997). Dietary flax seed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis 132:69-76.
15. Prasad K, Mantha SV, Muir AD, Westcott ND. (2000). Protective effect of secoisolariciresinol diglucoside against streptozotocin-induced diabetes and its mechanism. Mol Cell Biochem 206:141-50.
16. Prasad K, Mantha SV, Muir AD, Westcott ND. (1998). Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alpha-linolenic acid. Atherosclerosis 136:367-75.
17. Wasan KM, Subramanian R, Kwong M. (2003). Poloxamer 407- mediated alterations in the activities of enzymes regulating lipid metabolism in rats. J Pharm Pharmaceut Sci 6:189-97.
18. Westcott ND, Muir AD. (1996). Variation in flax seed lignan concentration with variety, location and year. In Proceedings of the 56th flax institute of the United States; Doublewood Inn, Fargo, North Dakota, 77-85.
19. Zanwar AA, Hegde MV, Bodhankar SL. (2010). In vitro antioxidant activity of ethanolic extract of Linum usitatissimum. Pharmacologyonline 1:683-96.
20. Zanwar AA, Hegde MV, Bodhankar SL. (2011). Cardioprotective activity of flax lignan concentrate extracted from seeds of Linum usitatissimum in isoprenalin induced myocardial necrosis in rats. Interdiscip Toxicol 4:90-7.
21. Zanwar AA, Hegde MV, Bodhankar SL. (2012). Antihyperlipidemic effect of flax lignan concentrate from seeds of Linum usitatissimum in Triton induced hyperlipidemic rats. Int J Pharmacol 8:355-63.
22. Zanwar AA, Hegde MV, Bodhankar SL. (2013). Protective role of concomitant administration of flax lignan concentrate and omega- 3-fatty acid on myocardial damage in doxorubicin-induced cardiotoxicity. Food Sci Human Wellness 2:29-38.